Immunohistochemical evidence for mesothelial origin of paratesticular adenomatoid tumour

B. Delahunt, J. N. Eble, D. King, P. B. Bethwaite, J. N. Nacey, A. Thornton

Research output: Contribution to journalArticlepeer-review

64 Scopus citations


Aims: To investigate the histogenesis of paratesticular adenomatoid tumour by use of immunohistochemical markers for a variety of carcinomas and mesothelioma. Methods and results: Immunohistochemical staining of sections from 12 cases of paratesticular adenomatoid tumour was undertaken using primary antibodies to antigens expressed by benign epithelial cells and carcinoma (cytokeratin AE1/AE3, cytokeratin 3413312, epithelial membrane antigen, MOC-31, BerEP4, CEA, B72.3, LEA.135, Leu M1), stromal and vascular markers (vimentin, CD34, factor VIII), and mesothelioma-associated antigens (thrombomodulin, HBME-1, OC 125) and p53 protein. There was absence of immunohistochemical expression of epithelial/carcinoma markers MOC-31, Ber-EP4, CEA, B72.3, LEA.135, Leu M1 and to factor VIII and CD34. All tumours expressed cytokeratin AE1/AE3, epithelial membrane antigen and vimentin, with weak expression of cytokeratin 34βE12 in 25% of tumours. Each tumour showed expression of thrombomodulin, HBME-1 and OC 125 in a membranous distribution, p53 protein expression was not detected. Conclusions: The immunohistochemical profile of paratesticular adenomatoid tumour is strongly supportive of a mesothelial cell origin.

Original languageEnglish (US)
Pages (from-to)109-115
Number of pages7
Issue number2
StatePublished - Mar 7 2000


  • Adenomatoid tumour
  • Immunohistochemistry
  • Mesothelial cell
  • Mesothelioma
  • Pathogenesis

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine
  • Cell Biology

Fingerprint Dive into the research topics of 'Immunohistochemical evidence for mesothelial origin of paratesticular adenomatoid tumour'. Together they form a unique fingerprint.

Cite this